Head and Neck Neoplasms  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00951379: Pioglitazone for Oral Premalignant Lesions

Terminated
2b
52
US, Canada, Europe
Pioglitazone hydrochloride, Actos, pioglitazone, placebo, PLCB, laboratory biomarker analysis
National Cancer Institute (NCI)
Oral Leukoplakia
03/14
03/14
NCT01655719: Pioglitazone in Thyroid Cancers

Completed
2
1
US
Pioglitazone, Actos
University of Michigan, National Cancer Institute (NCI)
Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
03/17
03/17

Download Options